208 related articles for article (PubMed ID: 36750870)
1. Subtype frequency, demographic features, treatment and outcome of Juvenile Arthritis in one Centre in Abu Dhabi in the United Arab Emirates.
Khawaja K; Kalas R; Almasri N
Pediatr Rheumatol Online J; 2023 Feb; 21(1):14. PubMed ID: 36750870
[TBL] [Abstract][Full Text] [Related]
2. Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates.
Khawaja K; Al-Maini M
Pediatr Rheumatol Online J; 2017 May; 15(1):41. PubMed ID: 28511684
[TBL] [Abstract][Full Text] [Related]
3. Summary of AHRQ's Comparative Effectiveness Review of Disease-Modifying Antirheumatic Drugs for Children with Juvenile Idiopathic Arthritis.
McMahan R; Balfe LM; Greene L
J Manag Care Pharm; 2012; 18(1 Suppl B):1-16. PubMed ID: 22376227
[TBL] [Abstract][Full Text] [Related]
4. Juvenile idiopathic arthritis managed in the new millennium: one year outcomes of an inception cohort of Australian children.
Tiller G; Buckle J; Allen R; Munro J; Gowdie P; Cox A; Akikusa J
Pediatr Rheumatol Online J; 2018 Nov; 16(1):69. PubMed ID: 30413164
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
[TBL] [Abstract][Full Text] [Related]
6. Factors determining resistance to conventional disease-modifying anti-rheumatic drug treatment in oligoarticular juvenile idiopathic arthritis.
Sener S; Aliyev E; Batu ED; Balik Z; Bayindir Y; Cam V; Basaran O; Bilginer Y; Ozen S
Clin Rheumatol; 2024 Jun; 43(6):2021-2026. PubMed ID: 38683443
[TBL] [Abstract][Full Text] [Related]
7. Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).
Davies R; Carrasco R; Foster HE; Baildam EM; Chieng SEA; Davidson JE; Ioannou Y; Wedderburn LR; Thomson W; Hyrich KL
Semin Arthritis Rheum; 2016 Oct; 46(2):190-195. PubMed ID: 27422803
[TBL] [Abstract][Full Text] [Related]
8. Subtype frequencies, demographic features, and remission rates in juvenile idiopathic arthritis - 265 cases from a Turkish center.
Çakan M; Aktay-Ayaz N; Keskindemirci G; Ekinci DY; Karadağ ŞG
Turk J Pediatr; 2017; 59(5):548-554. PubMed ID: 29745116
[TBL] [Abstract][Full Text] [Related]
9. Enthesitis-related arthritis is the most common category of juvenile idiopathic arthritis in Taiwan and presents persistent active disease.
Shih YJ; Yang YH; Lin CY; Chang CL; Chiang BL
Pediatr Rheumatol Online J; 2019 Aug; 17(1):58. PubMed ID: 31443722
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis.
Kip MMA; de Roock S; Currie G; Marshall DA; Grazziotin LR; Twilt M; Yeung RSM; Benseler SM; Vastert SJ; Wulffraat N; Swart JF; IJzerman MJ
Rheumatology (Oxford); 2023 Feb; 62(SI2):SI170-SI180. PubMed ID: 35583252
[TBL] [Abstract][Full Text] [Related]
11. When should the use of biological agents be considered in persistent oligoarticular juvenile idiopathic arthritis patients?
Polat MC; Çelikel E; Tekin ZE; Kurt T; Kaplan MM; Güngörer V; Tekgöz N; Sezer M; Karagöl C; Coşkun S; Öner N; Sezer S; Acar BÇ
Eur J Pediatr; 2024 Jun; 183(6):2725-2731. PubMed ID: 38554171
[TBL] [Abstract][Full Text] [Related]
12. Clinical remission and subsequent relapse in patients with juvenile idiopathic arthritis: predictive factors according to therapeutic approach.
Castillo-Vilella M; Giménez N; Tandaipan JL; Quintana S; Modesto C
Pediatr Rheumatol Online J; 2021 Aug; 19(1):130. PubMed ID: 34419078
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review.
Davies R; Gaynor D; Hyrich KL; Pain CE
Semin Arthritis Rheum; 2017 Apr; 46(5):584-593. PubMed ID: 27914689
[TBL] [Abstract][Full Text] [Related]
14. A retrospective study on 158 Thai patients with juvenile idiopathic arthritis followed in a single center over a 15-year period.
Vilaiyuk S; Soponkanaporn S; Jaovisidha S; Benjaponpitak S; Manuyakorn W
Int J Rheum Dis; 2016 Dec; 19(12):1342-1350. PubMed ID: 26176300
[TBL] [Abstract][Full Text] [Related]
15. Familial aggregation of juvenile idiopathic arthritis with other autoimmune diseases: Impact on clinical characteristics, disease activity status and disease damage.
Al-Mayouf SM; Alrasheedi A; Almsellati I; Hashad S; Khawaja K; Abdwani R; AlHashim S; Muzaffer M; Lotfy H; Almutairi N
Int J Rheum Dis; 2021 Aug; 24(8):1080-1085. PubMed ID: 34184820
[TBL] [Abstract][Full Text] [Related]
16. Features and Clinical Course of Infantile Juvenile Idiopathic Arthritis.
Campbell JA; Shenoi S
J Clin Rheumatol; 2022 Mar; 28(2):e609-e611. PubMed ID: 33843769
[TBL] [Abstract][Full Text] [Related]
17. Choice and switch of biologic drugs in juvenile idiopathic arthritis.
Şener S; Başaran Ö; Batu ED; Cüceoğlu MK; Balık Z; Aliyev E; Bayındır Y; Bilginer Y; Özen S
Turk J Pediatr; 2023; 65(6):980-989. PubMed ID: 38204313
[TBL] [Abstract][Full Text] [Related]
18. Cumulative Damage in Juvenile Idiopathic Arthritis: A Multicenter Study From the Pediatric Rheumatology Arab Group.
Al-Mayouf SM; Hashad S; Khawaja K; Alrasheedi A; Abdwani R; Abushhaiwia A; AlSuwaiti M; Alzyoud R; Al Abrawi S; Asiri A; Alshaikh M; Sharif E; Muzaffer M; Alsewairi W; Zlenti M; Kawaja E; Almutairi M; Majeed M; Lotfy H; AlMarri M; Almutairi N;
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):586-592. PubMed ID: 32886859
[TBL] [Abstract][Full Text] [Related]
19. Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis: 6-year efficacy and safety data from an open-label trial.
Foeldvari I; Constantin T; Vojinović J; Horneff G; Chasnyk V; Dehoorne J; Panaviene V; Sušić G; Stanevicha V; Kobusinska K; Zuber Z; Dobrzyniecka B; Nikishina I; Bader-Meunier B; Breda L; Doležalová P; Job-Deslandre C; Rumba-Rozenfelde I; Wulffraat N; Pedersen RD; Bukowski JF; Vlahos B; Martini A; Ruperto N;
Arthritis Res Ther; 2019 May; 21(1):125. PubMed ID: 31122296
[TBL] [Abstract][Full Text] [Related]
20. Outcome Monitoring and Clinical Decision Support in Polyarticular Juvenile Idiopathic Arthritis.
Buckley L; Ware E; Kreher G; Wiater L; Mehta J; Burnham JM
J Rheumatol; 2020 Feb; 47(2):273-281. PubMed ID: 31308202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
